Evaluation of a New mHealth Tympanometer
A Pilot Study to Assess Performance of a New Low-Cost Mobile Health Based Prototype Tympanometer
1 other identifier
interventional
39
0 countries
N/A
Brief Summary
Children in rural and underserved communities experience a disproportionately high burden of infection-related hearing loss, which is often preventable with timely identification and follow-up care. A tympanometer is a device that evaluates the health of the middle ear but is often not used in screening programs due to barriers of high cost and need for trained professionals such as audiologists to use the device. To address these barriers, a low cost, lay friendly, mobile health (mHealth) prototype tympanometer has been developed. In addition, a machine learning (ML) algorithm has been designed to guide lay users to interpret tympanometer results, overcoming the need for audiologists. Broad implementation of the lay friendly tympanometer and ML algorithm will transform screening in areas where prevalence of infection-related hearing loss is high, and access to specialty care is limited. In this study the prototype mHealth tympanometer will be evaluated against commercial tympanometry. It will be used by audiologists, an essential step before testing the performance of the device with lay users. Approximately 20 adult patients and 10 pediatric patients with various middle ear pathologies will be enrolled in the study, with the goal of obtaining 60 ears with data from both the prototype and commercial tympanometers. Audiologists will obtain tympanometry measurements on both ears of each participant and interpret the results, first with the prototype device and then with the commercial tympanometer that is typically used during a clinical evaluation. Tympanometry interpretation will include classification into one of 3 categories (Type A, B, or C). Agreement in results between the prototype and commercial devices will be assessed. Agreement between audiologist interpretations and the ML algorithm from the prototype mHealth tympanometer will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2022
CompletedFirst Posted
Study publicly available on registry
December 27, 2022
CompletedStudy Start
First participant enrolled
October 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2024
CompletedResults Posted
Study results publicly available
January 13, 2026
CompletedJanuary 13, 2026
January 1, 2026
1 month
December 13, 2022
December 5, 2025
January 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer
Audiologist will test each ear of the participant first with the prototype device, interpret the results into one of the three tympanogram categories (Type A/B/C) and record the results. The procedure will be repeated with a commercial device. Agreement between the two devices with respect to the classification categories will be assessed.
Same day as participant visit, up to 10 minutes
Classification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth Tympanometer
Tympanogram results collected using the prototype mHealth tympanometer will be run through the ML algorithm for classification into Type A/B/C. Agreement between the audiologist and the ML algorithm with respect to the classification categories will be assessed.
Same day as participant visit, up to 10 minutes
Study Arms (1)
Tympanometer Comparison
EXPERIMENTALBoth ears of each participant will be tested first with the prototype mHealth tympanometer followed by standard of care commercial tympanometer
Interventions
The prototype mHealth tympanometer functions similarly to a commercial tympanometer. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.
A commercial tympanometer routinely used as part of standard of care will be used as the comparison. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.
Eligibility Criteria
You may qualify if:
- Presenting to Audiology Clinic for evaluation, where tympanometry is warranted for testing at the discretion of the audiologist
- Presence of various middle ear health states/pathologies that result in Type A, B, C tympanograms
- English-speaking
You may not qualify if:
- Children or adults with cognitive disabilities
- Unable to provide consent/assent
- Individuals who are unable to sit still
- Any other condition that in the opinion of the investigator, might interfere with the safe conduct of the study or place the participant at increased risk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Samantha Kleindienst Robler, AuD, PhD
- Organization
- University of Arkansas for Medical Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2022
First Posted
December 27, 2022
Study Start
October 30, 2024
Primary Completion
December 10, 2024
Study Completion
December 10, 2024
Last Updated
January 13, 2026
Results First Posted
January 13, 2026
Record last verified: 2026-01